- Home
- Clinical Trials
Flu Vaccine Study Brisbane TA 000
Flu Vaccine Study
Taringa Brisbane
Please note that this study has now closed. However, we encourage you to pre-register your interest for future flu vaccine studies here.
Description
What to expect
Study details
Ages
18-49 or 60+ years of age.
Duration
The study runs for approx 3 weeks and involves 2 visits to the clinic and 1 vaccination.
Compensation
Eligible participants will be compensated for time and travel-related costs.
Eligibility Criteria
You may be eligible to take part if you:
- Are 18-49 OR 60 + years of age.
- Have not had a confirmed flu diagnosis in the past year.
- Have not received a flu vaccine this year.
Locations
Description
Influenza, commonly known as the flu, is a highly contagious respiratory illness caused by influenza viruses. Vulnerable populations such as the elderly, young children, and those with underlying health conditions are at a higher risk of severe illness from the flu.
Annual vaccination is the most effective way to prevent the flu and its complications, reducing the risk of illness and transmission within communities.
What to expect
We are conducting a research study exploring an investigational flu vaccine. This vaccine contains an additional antigen that aims to enhance protection against different strains of influenza.
The study has a duration of approximately 3-weeks and involves 2 visits to the clinic and 1 vaccination.
Eligible participants will be compensated for time and travel-related costs.
By joining this study, you could help make immunisation against the flu more effective.
This study is now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for future flu vaccine studies here.